An Open Label Extension of a Study of Topiramate in Chronic Migraine.

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

August 31, 2005

Conditions

Migraine

Interventions

DRUG

topiramate

All Listed Sponsors

collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00210873 - An Open Label Extension of a Study of Topiramate in Chronic Migraine. | Biotech Hunter | Biotech Hunter